← All trials
NCT04295109
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 2, 2020
- Primary completion
- Jul 31, 2020
- Completion date
- Jul 31, 2020
- First posted
- Mar 4, 2020
- Last posted
- Mar 4, 2020
- Enrollment
- 105
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Nanjing Medical UniversityLead sponsor
- Nanjing Medical UniversityReponsible party - principal investigator
- Nanjing Medical UniversityOverall official - principal investigator
- Nanjing Medical UniversityStudy chair
- Nanjing Medical UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.